Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer's disease: a PET substudy interim analysis. - Klein, Gregory; Delmar, Paul; Voyle, Nicola; Rehal, Sunita; Hofmann, Carsten; Abi-Saab, Danielle; Andjelkovic, Mirjana; Ristic, Smiljana; Wang, Guoqiao; Bateman, Randall; Kerchner, Geoffrey A.; Baudler, Monika; et al. (Alzheimer's Research & Therapy, 2019)